Targeting the target: a step forward for the treatment of non-small-cell lung cancer.
Jean Yves
JY
Douillard
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D008175:Lung Neoplasms / Q000188:drug therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D066246:ErbB Receptors; D020794:Receptor Protein-Tyrosine Kinases